A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RARα mutation

Blood

Volumn 89, Issue 12, 1997, Pages 4282-4289

  Shao, Wenlin ^a   Benedetti, Laura ^a   Lamph, William W ^a   Nervi, Clara ^a   Miller Jr , Wilson H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CELL STRAIN HL 60; CONTROLLED STUDY; DIMERIZATION; DNA RESPONSIVE ELEMENT; DRUG RESISTANCE; GENE FUSION; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL;

EID: 0030992905     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.12.4282     Document Type: Article

References (45)

1. Pandolfi PP, Grignani F, Alcalay M, Mencarelli A, Biondi A, Lo Coco F, Pelicci PG: Structure and origin of the acute promyelocytic leukemia myl/RARα cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6:1285, 1991
2. de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A: The PML-RAR alpha fusion mRNA generated by the t(15; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675, 1991
3. Kakizuka A, Miller WH Jr, Umesono K, Warrell RP Jr, Frankel SR, Murty VV, Dmitrovsky E, Evans RM: Chromosomal translocation t(15; 17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66:663, 1991
4. Kastner P, Perez A, Lutz Y, Rochette-Egly C, Gaub MP, Durand B, Lanotte M, Berger R, Chambon P: Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): Structural similarities with a new family of oncoproteins. EMBO J 11:629, 1992
5. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Peschle C, Nicoletti I. Pelicci PG: The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423, 1993
6. Grignani F, Testa U, Fagioli M, Barberi T, Masciulli R, Mariani G, Peschle C, Pelicci P: Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells. Cancer Res 55:440, 1995
7. Altabef M, Garcia M, Lavau C, Bae S, Dejean A, Samarut J: A retrovirus carrying the promyelocyte-retinoic acid receptor PML-RARα fusion gene transforms haematopoietic progenitors in vitro and induces acute leukaemias. EMBO J 15:2707, 1996
8. Warrell RPJ, de The H, Wang Z, Degos L: Acute promyelocytic leukemia. N Engl J Med 329:177, 1993
9. Gudas LJ: Retinoids, retinoid-responsive genes, cell differentiation, and cancer. Cell Growth Differ 3:655, 1993
10. Degos L, Dombret H, Chomienne C, Daniel MT, Miclea JM, Chastang C, Castaigne S, Fenaux P: Review: All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 85:2643, 1995
11. Dyck JA, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, Evans RM: A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76:333, 1994
12. Raelson JV, Nervi C, Rosenauer A, Benedetti L, Monczak Y, Pearson M, Pelicci PG, Miller WH Jr: The PML/RARα oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. Blood 88:2826, 1996
13. Warrell RP Jr, Frankel SR, Miller WH Jr, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS, Dmitrovsky E: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324:1385, 1991
14. Castaigne S, Chomienne C, Daniel MT, Berger R, Fenaux P, Degos L: All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76:1704, 1990
15. Chen ZX, Xue YQ, Zhang R, Tao RF, Xia XM, Li C, Wang W, Zu WY, Yao XZ, Ling BJ: A clinical and experimental study on all-trans retinoic acid treated acute promyelocytic leukemia patients. Blood 78:1413, 1991
16. Muindi J, Frankel SR, Miller WH Jr, Jakubowski A, Scheinberg DA, Young CW, Dmitrovsky E, Warrell RP Jr: Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. Blood 79:299, 1992 (erratum 80:855, 1992)
17. Warrell RP Jr: Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies, and implications. Blood 82:1949, 1993
18. Cornic M, Delva L, Guidez F, Balitrand N, Degos L, Chomienne C: Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients. Cancer Res 52:3329, 1992
19. Miller WH, Jr, Jakubowski A, Tong WP, Miller VA, Rigas JR, Benedetti F, Gill GM, Truglia JA, Ulm E, Shirley M, Warrell RP Jr: 9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia. Blood 85:3021, 1995
20. Pratt MAC, Kralova J, McBurney MW: A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell. Mol Cell Biol 10:6445, 1990
21. Robertson KA, Emami B, Collins SJ: Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood 80:1885, 1992
22. Doré BT, Momparler RL: Mutation in the ligand-binding domain of the retinoic acid receptor alpha in HL-60 leukemic cells resistant to retinoic acid and with increased sensitivity to vitamin D3 analogs. Leuk Res 20:761, 1996
23. Lanotte M, Martin-Thouvenin V, Najman S, Ballerini P, Valensi F, Bergen R: NB4, a maturation inducible cell line with t(15; 17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77:1080, 1991
24. Duprez E, Ruchaud S, Houge G, Martin-Thouvenin V, Valensi F, Kastner P, Berger R, Lanotte M: A retinoid acid 'resistant' t(15; 17) acute promyelocytic leukemia cell line: Isolation, morphological, immunological, and molecular features. Leukemia 6:1281, 1992
25. Dermime S, Grignani F, Clerici M, Nervi C, Sozzi G, Talamo GP, Marcheis E, Formelli F, Parmiani G, Pelicci PG, Gambacorti-Passerini C: Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RARα protein. Blood 82:1573, 1993
26. Rosenauer A, Raelson JV, Nervi C, Eydoux P, DeBlasio A, Miller WH Jr: Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines. Blood 88:2671, 1996
27. Chirgwin JM, Przybyla AF, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. J Biochem 18:5294, 1979
28. Nervi C, Grippo JF, Sherman MI, George MD, Jetten AM: Identification and characterization of nuclear receptor acid-binding activity in human myeloblastic leukemia HL-60 cells. Proc Natl Acad Sci USA 86:5854, 1989
29. Nervi C, Poindexter EC, Grignani F, Pandolfi PP, Lo Coco F, Avvisati G, Pelicci PG, Jetten AM: Characterization of the PML-RARα chimeric product of the acute promyelocytic leukemia-specific t(15; 17) translocation. Cancer Res 52:3687, 1992
30. Neuman JR, Morency CA, Russian KO: A novel rapid assay for chloramphenicol acetyl transferase gene expression. Biotechniques 5:444, 1987
31. Zinn K, DiMaio D, Maniatis T: Identification of two distinct regulatory regions adjacent to the human β-interferon gene. Cell 34:865, 1984
32. Melton D, Krieg P, Rebacylilati M, Maniatis T, Zinn K, Green M: Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing SP6 promoters. Nucleic Acids Res 12:7035, 1984
33. Kishimoto T. O'Connor K, Lee A, Roberts TM, Springer TA: Cloning of the β subunit of the leukocyte adhesion proteins: homology to an extracellular matrix receptor defines a novel supergene family. Cell 48:681, 1987
34. Rochette-Egly C, Oulad-Abdelghani M, Staub A, Pfister V, Scheuer I, Chambon P, Gaub MP: Phosphorylation of the retinoic acid receptor-alpha by protein kinase A. Mol Endocrinol 9:860, 1995
35. Renaud J, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D: Crystal structure of the RAR-Γ ligand-binding domain bound to all-trans retinoic acid. Nature 378:681, 1995
36. Perez A, Kastner P, Sethi S, Lutz Y, Reibel C, Chambon P: PML-RAR homodimers: Distinct DNA binding properties and heteromeric interactions with RXR. EMBO J 12:3171, 1993
37. de The H, del Mar Vivanco-Ruiz M, Tiollais P, Stunnenberg H, Dejean A: Identification of a retinoic acid responsive element in the retinoic acid receptor β gene. Nature 343:177, 1990
38. Mangelsdorf DJ, Umesono K, Evans RM: The retinoid receptors, in Sporn MB, Roberts AB, Goodman DS (eds): The Retinoids: Biology, Chemistry, and Medicine. New York, NY, Raven, 1994, p 319
39. Drach J, Zhao S, Malavasi F, Mehta K: Rapid induction of CD38 antigen on myeloid leukemia cells by all trans-retinoid acid. Biochem Biophys Res Commun 195:545, 1993
40. Drach J, McQueen T, Engel H, Andreeff M, Robertson KA, Collins SJ, Malavasi F, Mehta K: Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-α. Cancer Res 54:1746, 1994
41. Benedetti L, Grignani F, Scicchitano BM, Jetten AM, Diverio D, Lococo F, Avvisati G, Gambacortipasserini C, Adamo S, Levin AA, Pelicci G, Nervi C: Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARα-mediated increase of type II transglutaminase. Blood 87:1939, 1996
42. Li Y, Said F, Gallagher RE: Retinoic acid-resistant HL-60 cells exclusively contain mutant retinoic acid receptor-α. Blood 83:3298, 1994
43. Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R, Naoe T: Accelerated degradation of PML-retinoic acid receptor α (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: Possible role of the proteasome pathway. Cancer Res 56:2945, 1996
44. Ahn MJ, Nason-Burchenal K, Moasser MM, Dmitrovsky E: Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML. Oncogene 10:2307, 1995
45. Jansen JH, Mahfoudi A, Rambaud S, Lavau C, Wahli W, Dejean A: Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways. Proc Natl Acad Sci USA 92:7401, 1995